Home » Endo Buys Rights to Testosterone Replacement Gel
Endo Buys Rights to Testosterone Replacement Gel
Endo Pharmaceuticals signed an agreement valued at up to $200 million with ProStrakan Group for the exclusive rights to commercialize Fortesta, a testosterone replacement gel, in the United States.
Philadelphia Business Journal
Philadelphia Business Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May